Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bang

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 14, 2023
Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD RegistryPeter Bang, Michel Polak, Artur Bossowski, et al.
Journal of Neuroscience Research|September 18, 2003
Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitroN David Aberg, Fredrik Blomstrand, Maria A I Aberg, et al.
Clinical Endocrinology|May 1, 2012
Identification and management of poor response to growth-promoting therapy in children with short staturePeter Bang, S Faisal Ahmed, Jesús Argente, et al.
The Journal of Clinical Endocrinology and Metabolism|February 27, 2016
Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth CharacteristicsKerstin Albertsson-Wikland, Anton Mårtensson, Lars Sävendahl, et al.
Orphanet Journal of Rare Diseases|October 7, 2023
Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspectivePhilippe F Backeljauw, Mary Andrews, Peter Bang, et al.
BMC Research Notes|August 9, 2012
Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birthAlemnew F Dagnew, Jemal Hussein, Markos Abebe, et al.
Molecular and Cellular Neurosciences|October 11, 2003
IGF-I has a direct proliferative effect in adult hippocampal progenitor cellsMaria A I Aberg, N David Aberg, Theo D Palmer, et al.
BMJ Open|February 3, 2022
Group cognitive behavioural therapy with virtual reality exposure versus group cognitive behavioural therapy with in vivo exposure for social anxiety disorder and agoraphobia: a protocol for a randomised clinical trialBenjamin Arnfred, Peter Bang, Carsten Hjorthøj, et al.
Vaccine|November 10, 2009
Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimenYasir A W Skeiky, Jes Dietrich, Todd M Lasco, et al.
Nature Communications|November 23, 2021
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patientsSynne Jenum, Kristian Tonby, Corina S Rueegg, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|August 14, 2023
Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD RegistryPeter Bang, Michel Polak, Artur Bossowski, et al.
Journal of Neuroscience Research|September 18, 2003
Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitroN David Aberg, Fredrik Blomstrand, Maria A I Aberg, et al.
Clinical Endocrinology|May 1, 2012
Identification and management of poor response to growth-promoting therapy in children with short staturePeter Bang, S Faisal Ahmed, Jesús Argente, et al.
The Journal of Clinical Endocrinology and Metabolism|February 27, 2016
Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth CharacteristicsKerstin Albertsson-Wikland, Anton Mårtensson, Lars Sävendahl, et al.
Orphanet Journal of Rare Diseases|October 7, 2023
Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspectivePhilippe F Backeljauw, Mary Andrews, Peter Bang, et al.
BMC Research Notes|August 9, 2012
Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birthAlemnew F Dagnew, Jemal Hussein, Markos Abebe, et al.
Molecular and Cellular Neurosciences|October 11, 2003
IGF-I has a direct proliferative effect in adult hippocampal progenitor cellsMaria A I Aberg, N David Aberg, Theo D Palmer, et al.
BMJ Open|February 3, 2022
Group cognitive behavioural therapy with virtual reality exposure versus group cognitive behavioural therapy with in vivo exposure for social anxiety disorder and agoraphobia: a protocol for a randomised clinical trialBenjamin Arnfred, Peter Bang, Carsten Hjorthøj, et al.
Vaccine|November 10, 2009
Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimenYasir A W Skeiky, Jes Dietrich, Todd M Lasco, et al.
Nature Communications|November 23, 2021
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patientsSynne Jenum, Kristian Tonby, Corina S Rueegg, et al.
Pageof 7